Country Singer Jana Kramer Partners with Both Ava Fertility and Duchesnay on Pregnancy Promotions

Since becoming pregnant with her second child, country singer and actress Jana Kramer has become a spokesperson for Ava’s fertility tracking bracelet and pharmaceutical company Duchesnay USA for their morning sickness drug Bonjesta. Kramer says the Ava fertility tracking bracelet helped her conceive and that Bonjesta has helped to manage her early pregnancy symptoms.

Kramer has been outspoken about her experiences with secondary infertility and suffering multiple miscarriages after trying to conceive with husband Mike Caussin. Kramer and Caussin currently have a two-year-old daughter and are expecting their next baby later this year.

“I was overwhelmed with how much positive support I received when I chose to share my difficult experiences trying to add a sibling for Jolie Rae and expand our family,” said Kramer. “It’s so important that we women work together to lift the veil on this ‘silent struggle’ of secondary infertility and support each other.”

The Ava bracelet measures physiological changes in heart rate, temperatures and seven other variables that are associated with fertility hormones estradiol and progesterone. This data helps women to identify their fertile window each month with an accuracy of almost 90 percent to give them a better chance conceiving.

“Ava let me know that the fertile days in my cycle were different from those I had identified before using other fertility tracking methods,” said Kramer, who is among more than 10,000 women who have reported becoming pregnant as a result of using the Ava bracelt. “Once we followed the Ava data and tried on the ‘right’ days, I got pregnant within the first cycle wearing the bracelet.”

Now that Kramer is pregnant again, she’s also partnered up with Duchesnay to promote the company’s reformulated version of the morning sickness drug Bonjesta. Kramer previously worked with Duchesnay during her first pregnancy to raise awareness of morning sickness and the fact that pregnant women have options when it comes to safely treating those symptoms.

“About five weeks into my pregnancy I started feeling nauseous and knew I couldn’t keep my ‘secret trimester’ a secret for much longer,” said Kramer. “I have a great relationship with my doctor and I spoke to him right away about treatment options because diet and lifestyle changes weren’t working for me. I had taken medication during my prior pregnancies to help me manage my symptoms – but this time I was told about Bonjesta, a new formulation of the drug combination I took before that is designed to be fast-acting and long-lasting, which I found very easy to incorporate into my daily routine because I can take fewer tablets per day.”

According to studies cited by Duchesnay, up to 85 percent of pregnant women will experience morning sickness at some point during their pregnancy. For some women, the symptoms of nausea and vomiting can be managed by changes in diet and lifestyle, but for others, medical intervention may be necessary. Women diagnosed with hyperemesis gravidarum – a severe form of morning sickness – may need to be hospitalized as a result of their symptoms, and Duchesnay reports that it’s unknown whether Bonjesta would be an effective treatment for these women.

“We are thrilled to be working with Jana again. As a member of our Duchesnay family it is great to be able to help her manage her morning sickness so she can keep up with her busy professional and family life,” said Dean Hopkins, Duchesnay USA’s General Manager. “Our hope is to educate expectant women and their families about morning sickness, and empower and encourage them to speak with their doctors if they are experiencing symptoms.”